Skip to main content
Georgia Public Broadcasting Logo
  • Watch

    Featured Specials and Programs

    • All Creatures Great and Small
    • Antiques Roadshow
    • PBS News Hour
    • Miss Scarlet & The Duke
    • Finding Your Roots
    • Doc Martin
    All Programs

    GPB Originals

    • Georgia Legends
    • Lawmakers
    • A Fork in the Road
    • View Finders
    • Georgia Outdoors
    • Your Fantastic Mind
    GPB Originals

    Browse by Genre

    • Arts & Music
    • Culture
    • Drama
    • Food
    • History
    • News & Public Affairs
    • TV Schedule
    • GPB Programs
    • PBS Passport
    • TV Highlights this Week
    • PBS KIDS
    • Ways to Watch
    • Newsletters
    • Contact GPB
  • Listen

    Featured Programs

    • The Daily
    • Morning Edition
    • All Things Considered
    • Serendipity
    • John Lemley's City Cafe
    • Fresh Air
    • Here and Now
    • Code Switch/Life Kit
    • Wait Wait... Don't Tell Me!
    All Programs

    Podcasts

    • GA Today
    • Salvation South
    • Lawmakers: Spotlight
    • Football Fridays in Georgia
    • Narrative Edge
    • Peach Jam Podcast
    • A Fork in the Road
    • Radio Schedule
    • GPB Classical
    • Radio Programs
    • Podcasts
    • GPB News
    • Find Your Station
    • Ways to Listen
    • Contact GPB
    • Newsletters
  • Learn

    Featured

    • Chemistry Matters
    • Classroom Conversations Podcast
    • GASHA Go! World
    • Georgia Farmcraft®
    • Georgia Classroom
    • Georgia Studies Collection
    • Econ Express
    • Learning in Action
    • Let’s Go Enviro
    • Let's Learn GA!
    • Lights, Camera, Budget!
    • Live Explorations
    • Physics in Motion
    • Professional Learning
    • Student Voices Collective
    • Virtual Field Trips
    • VR in the Classroom
    • Writers Contest

    For Kids & Teachers

    • GPB Games
    • PBS KIDS
    • PBS LearningMedia

    • on Twitter
    • on Facebook
    • on Instagram
    • on YouTube
    • on Email
  • News

    Featured Programs & Series

    • Lawmakers
    • Lawmakers: Beyond the Dome
    • 1A
    • Battleground: Ballot Box
    • GA Today Podcast
    • Storycorps
    • Narrative Edge

    More GPB News

    • Politics
    • Georgia News
    • Justice
    • Arts & Life
    • Health
    All GPB News
    • Radio Schedule
    • Radio Stations
    • GPB Apps
    • Podcasts
    • Contact GPB News
    • Follow Us on Apple News
    • Newsletters
  • Sports

    GHSA Sports

    • Football
    • Basketball
    • Cheerleading
    • On Demand
    • GPB Sports Blog
    All Sports

    High School Football

    • Scores & Schedule
    • On Demand
    • Teams
    • Rankings
    • Brackets
    • Heads Up Georgia
    Football Home
    • GPB Sports App
    • GPB Sports Blog
    • GPB Sports OnDemand
  • Events

    Browse by Type

    • Community
    • Donor
    • Kids & Family
    • Screenings
    All Events

    Browse by Category

    • Education
    • News
    • Sports
    • Television

    Sign up to receive GPB Event announcements via Email.

    Sign up

    • on Twitter
    • on Facebook
    • on Instagram
  • Kids & Families

    For Kids

    • Video
    • Games

    For Parents & Caregivers

    • Kids & Families Blog
    • Kids & Families Events
    • GPB KIDS - Ways to Watch
  • Support Us

    Support GPB

    • Ways to Give
    • Planned Giving
    • Sustainers
    • GPB Passport
    • Leadership Giving
    • Corporate Sponsorship
    • Vehicle Donations
    • GPB Next
    • Matching Gifts
  • Search
GPB Passport icon GPB Passport icon Passport
GPB donate icon GPB donate icon Donate

Media Utility

  • TV Schedule
  • Podcasts
  • Apps

Don't Miss

Don't Miss:

  • Extreme Weather Hub
  • TV Highlights This Week
  • Watch: GPB's Lawmakers
Listen Live Listen Live Watch Live Watch Live
GPB Passport icon GPB Passport icon Passport
GPB donate icon GPB donate icon Donate

News Articles: Pharmaceuticals

Centers for Medicare & Medicaid Services Administrator Mehmet Oz (left) and National Design Studio chief Joe Gebbia talk about TrumpRx.gov during its rollout Thursday.

Tagged as: 

  • Health

White House unveils TrumpRx website for medication discounts

Under Trump administration deals to lower drug prices, pharmaceutical companies are offering some of their drugs at discounted prices through a new website called TrumpRx.gov.

February 06, 2026
|
By:
  • Sydney Lupkin
Novo Nordisk lowered its sales forecast for obesity drug Wegovy, citing competition from compounded versions.

Tagged as: 

  • Health

Drugmaker Novo Nordisk slashes Wegovy sales forecasts, blaming compounding

Compounding pharmacies are crimping sales of Novo Nordisk's obesity drug Wegovy by making what are essentially copies of the name-brand medicine. The company says it trying to stop them.

July 29, 2025
|
By:
  • Sydney Lupkin
President Trump, joined by National Institutes of Health Director Jay Bhattacharya and Health and Human Services Secretary Robert F. Kennedy Jr., talks about an executive order aimed at reducing the cost of prescription drugs.

Tagged as: 

  • Health

Trump signs an order to reduce drug prices, but it's unclear how it would work

President Trump wants to lower drug prices in the U.S. by tying them to the prices paid in other developed countries. The pharmaceutical industry has long opposed the approach.

May 12, 2025
|
By:
  • Sydney Lupkin
An Eli Lilly & Co. Zepbound injection pen.

Tagged as: 

  • Health

Eli Lilly sues companies selling alternative versions of its weight loss drug

The drug company Eli Lilly is suing four telehealth companies for allegedly selling copies made by compounding pharmacies of its drug Zepbound.

April 23, 2025
|
By:
  • Sydney Lupkin
Atlantic Salmon, salmo salar, Adult, Quebec in Canada

Tagged as: 

  • Science

Anxiety drugs found in rivers make salmon take more risks

New research suggests that pharmaceutical pollution can change the behavior of salmon in the wild.

April 14, 2025
|
By:
  • Jonathan Lambert
Myra Solano Garcia in Upland, California, 2024. Garcia has been living with Alzheimer's disease and is taking one of the two approved drugs on the market to try to slow its symptoms.

Tagged as: 

  • Health

Alzheimer's was taking her memory, so she started taking a new drug

Myra Solano Garcia, who has Alzheimer's, says the drug Kisunla may be one reason she can still drive, cook, and sing.

February 27, 2025
|
By:
  • Jon Hamilton
Key guidance to industry on enhancing diversity in clinical trials of cancer drugs disappeared from the Food and Drug Administration website.

Tagged as: 

  • Health

The FDA pulls key DEI initiative for cancer studies from its website

A Food and Drug Administration project to promote diversity in clinical studies of cancer treatments was removed from the agency's website, as the Trump administration halts DEI initiatives.

January 25, 2025
|
By:
  • Sydney Lupkin
The Food and Drug Administration approved Cobenfy, a twice-a-day medication that is a new kind of treatment for schizophrenia in adults.

Tagged as: 

  • Health

A new kind of drug for schizophrenia promises fewer side effects

A medicine that sidesteps the brain's dopamine receptors to reach different targets represents a new approach to schizophrenia treatment. The Food and Drug Administration approved it Thursday.

September 28, 2024
|
By:
  • Sydney Lupkin
GPB  NPR

Tagged as: 

  • Health

Medicare negotiations for lower drug prices near the finish line

Medicare's new authority to negotiate lower prescription drug prices represents a signature accomplishment of the Biden-Harris administration. Here's what to know as the first set of talks wraps up.

July 30, 2024
|
By:
  • Sydney Lupkin
Health insurers' lists of covered drugs have gotten tighter.

Tagged as: 

  • Health

Health insurers cover fewer drugs and make them harder to get

Insurance companies are covering fewer drugs than they used to, and patients have to jump through more hoops to get many of them. When shopping for insurance, check for coverage of the drugs you need.

June 27, 2024
|
By:
  • Sydney Lupkin
The U.S. is the most lucrative market for drugmakers, but they often pay more in taxes overseas.

Tagged as: 

  • Business

Drugmakers' low U.S. taxes belie their high sales

Most of the largest pharmaceutical companies report losing money in the United States, despite the majority of their sales coming from Americans. The result is lower U.S. taxes for the companies.

April 15, 2024
|
By:
  • Sydney Lupkin
Vermont Sen. Bernie Sanders, chairman of the Senate Health, Education, Labor, and Pensions Committee, pressed executives from Bristol Myers Squibb, Merck and Johnson & Johnson about the prices they charge for drugs in the U.S.

Tagged as: 

  • Health

Senators ask CEOs why their drugs cost so much more in the U.S.

The Senate HELP committee questioned pharmaceutical CEOs about how much more Americans pay for the same drugs sold for less in Canada, Japan and Europe.

February 08, 2024
|
By:
  • Sydney Lupkin
Drug price hikes appear to be moderate this year, with some drug prices falling.

Tagged as: 

  • Health

What to know about January's annual drug price hikes

Spoiler: There are some decreases this year, too. Here's an overview of the changing prices and what to make of them.

January 18, 2024
|
By:
  • Sydney Lupkin
The former Akorn pharmaceutical plant in Decatur, Ill., that made a wide range of generic drugs used in hospitals is being reopened under new ownership.

Tagged as: 

  • Health

How rock-bottom prices drive shortages of generic drugs used in hospitals

Hospitals rely on scores of generic drugs given by injection. But these workhorses are often in short supply. Cheap prices have led to factory closures that leave the supply chain vulnerable.

December 28, 2023
|
By:
  • Sydney Lupkin
A new precision medicine test could help doctors and patients zero in on the right arthritis drug much sooner. But insurance coverage and drug company incentives are hurdles to widespread use.

Tagged as: 

  • Health Care

A new test could save arthritis patients time, money and pain. But will it be used?

Stories of chronic pain, drug-hopping, and insurance meddling are all too common among patients with rheumatoid arthritis. Precision medicine offers new hope.

December 20, 2023
|
By:
  • Arthur Allen
  • Load More
Georgia Public Broadcasting Home

Newsletter Signup

Sign Up For Our Newsletters

Connect with GPB

  • Connect with GPB on Facebook
  • Connect with GPB on Instagram
  • Connect with GPB on Twitter
  • Connect with GPB on YouTube
  • Connect with GPB on Apple News

Footer

Footer First Nav (Main Menu)

  • Watch
  • Listen
  • Learn
  • News
  • Sports
  • Events
  • Kids & Families
  • Support Us
  • Search

Footer Second Nav Menu

  • Help Center
  • About GPB
  • Contact Us
  • Closed Captioning
  • Directions
  • Studio Production
  • Program Submissions
  • Shop GPB

Footer Third Nav Menu

  • Support Us
  • Careers
  • Accessibility
  • FCC Public Files
  • Drawing Rules
  • News Media Request
  • Open Records and Document Retention Policy
  • Privacy Policy

Georgia Public Broadcasting

260 14th St. NW
Atlanta, GA 30318
United States

(404) 685-2400 In Atlanta
(800) 222-4788 Outside Atlanta
ask@gpb.org

Newsletter Signup

Sign Up For Our Newsletters

Connect with GPB

  • Connect with GPB on Facebook
  • Connect with GPB on Instagram
  • Connect with GPB on Twitter
  • Connect with GPB on YouTube
  • Connect with GPB on Apple News
© Copyright 2026, Georgia Public Broadcasting. All Rights Reserved. Georgia Public Radio® GPTV®